Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
25%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_2
1
11%
Ph phase_3
1
11%
Ph phase_4
3
33%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
3(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(8)
Terminated(1)

Detailed Status

Completed8
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (20.0%)
Phase 31 (20.0%)
Phase 43 (60.0%)

Trials by Status

terminated111%
completed889%

Recent Activity

0 active trials
Showing 5 of 9
completed

Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice

NCT01106118
completedphase_4

Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome

NCT00738400
completedphase_4

FDA Phase IV - Commitment - Retinal Function Study

NCT00461565
completed

LEVITRA® Specific Drug Use Investigation. To Investigate the Safety Profile in Combination Use With Alpha-blockers

NCT01207947
completedphase_2

Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate Hypertrophy

NCT00461123
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT01106118

Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice

Completed
NCT00738400Phase 4

Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome

Completed
NCT00461565Phase 4

FDA Phase IV - Commitment - Retinal Function Study

Completed
NCT01207947

LEVITRA® Specific Drug Use Investigation. To Investigate the Safety Profile in Combination Use With Alpha-blockers

Completed
NCT00461123Phase 2

Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate Hypertrophy

Completed
NCT00668135Phase 4

Assessment of Vardenafil in Patients With Erectile Dysfunction in Asia

Completed
NCT00909233

LEVITRA® 20mg Special Drug Use Investigation (Long-term)

Completed
NCT01215409

Real Life Safety and Efficacy of Vardenafil

Terminated
NCT00654680Phase 3

Evaluating the Efficacy and Safety of Vardenafil in Patients Erectile Dysfunction Solely Secondary to Spinal Cord Injury

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9